Regulatory T cell and autoimmune diseases

5Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.

Abstract

CD25+CD4+ regulatory T cells are naturally anergic and suppressive. They Differentiate through thymus as professional regulator to control immunological self-tolerance in the periphery. When they are depleted from normal animals, various organ-specific autoimmune diseases spontaneously develop, and reconstitution of regulatory T cells prevents the diseases. Transcriptional factor FoxP3 is the master gene for differentiation and function of regulatory T cells. Mutation of FoxP3 gene causes development of autoimmune disease in both human and mouse. There are accumulating reports that regulatory T cells are abnormal in their number or function in several animal models and also patients with autoimmune diseases. These findings indicate that regulatory T cells are involved in the pathogenesis of many autoimmune diseases. Regulatory T cells can also be employed for the treatment of autoimmune diseases. Further studies of regulatory T cells, especially the detection of their specific markers and the development of the method to propagate them in an antigen-specific manner, will facilitate their clinical application. © 2005, The Japan Society for Clinical Immunology. All rights reserved.

Cite

CITATION STYLE

APA

Tanaka, S., & Sakaguchi, S. (2005). Regulatory T cell and autoimmune diseases. Japanese Journal of Clinical Immunology, 28(5), 291–299. https://doi.org/10.2177/jsci.28.291

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free